Dolby Laboratories (DLB) EBITDA Margin Growth (1y) (2010 - 2026)
Dolby Laboratories (DLB) EBITDA Margin Growth (1y) (2010 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (1y) (Qtr) |
| 1 |
Cintas |
81.31 Bn |
81.12 Bn |
1.45 Bn |
-15.00 |
| 2 |
Rentokil Initial |
73.75 Bn |
71.25 Bn |
- |
- |
| 3 |
Relx |
60.28 Bn |
60.04 Bn |
- |
- |
| 4 |
Thomson Reuters |
38.09 Bn |
37.23 Bn |
- |
-11,714.00 |
| 5 |
Copart |
25.18 Bn |
21.85 Bn |
732.88 Mn |
27.00 |
| 6 |
Global Payments |
21.29 Bn |
16.10 Bn |
1.70 Bn |
-2,096.00 |
| 7 |
Rb Global |
20.33 Bn |
20.14 Bn |
927.90 Mn |
52.00 |
| 8 |
UL Solutions |
17.42 Bn |
17.18 Bn |
381.00 Mn |
274.00 |
| 9 |
Aramark |
15.00 Bn |
14.59 Bn |
426.39 Mn |
41.00 |
| 10 |
Dolby Laboratories |
4.68 Bn |
4.61 Bn |
350.90 Mn |
-61.00 |
| Date | Value |
|---|
| Mar 27, 2026 |
-61.00 |
| Dec 26, 2025 |
-445.00 |
| Sep 26, 2025 |
-554.00 |
| Jun 27, 2025 |
236.00 |
| Mar 28, 2025 |
-73.00 |
| Dec 27, 2024 |
139.00 |
| Sep 27, 2024 |
1,641.00 |
| Jun 28, 2024 |
740.00 |
| Mar 29, 2024 |
84.00 |
| Dec 29, 2023 |
-711.00 |
| Sep 29, 2023 |
-1,095.00 |
| Jun 30, 2023 |
-1,039.00 |
| Mar 31, 2023 |
1,609.00 |
| Dec 30, 2022 |
233.00 |
| Sep 30, 2022 |
-442.00 |
| Jul 1, 2022 |
-382.00 |
| Apr 1, 2022 |
-1,307.00 |
| Dec 31, 2021 |
-1,650.00 |
| Sep 24, 2021 |
307.00 |
| Jun 25, 2021 |
573.00 |
